1. IMS Health Incorporated.
http://www.imshealth.com
. April 26 (2002).
2. Kaitin, K.I., ed. Biotech products proliferate, but total development times lengthen. Tufts Center for the Study of Drug Development Impact Report Vol. 3, no. 6 (2001).
3. Ashton, G. Growing pains for biopharmaceuticals. Nat. Biotechnol. 19, 307–311 (2001).
4. Pharmaprojects. Update Analysis. Pharmaprojects Monthly Newsletter May (2002), pp.1–11.
5. Anonymous. The future at FDA. Regulatory Affairs Focus, January (2000), pp.18–20.